• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Monitoring of in vitro fat digestion by electron paramagnetic resonance spectroscopy.

作者信息

Rübe Andrea, Klein Sandra, Mäder Karsten

机构信息

Department of Pharmacy, Institute of Pharmaceutics and Biopharmaceutics, Martin Luther University Halle-Wittenberg, Wolfgang-Langenbeck-Str. 4, 06120 Halle/Saale, Germany.

出版信息

Pharm Res. 2006 Sep;23(9):2024-9. doi: 10.1007/s11095-006-9069-3. Epub 2006 Aug 10.

DOI:10.1007/s11095-006-9069-3
PMID:16900409
Abstract

PURPOSE

The distribution of drugs between water, oil and mixed micelles after the oral application of lipid-based drug delivery systems affects their absorption rate. Since it has not been previously possible to monitor this process online during in vitro lipolysis, it was our aim to develop a suitable real-time method.

MATERIALS AND METHODS

To follow the fate of a co-administered drug during fat digestion, the spin probe tempol benzoate was incorporated as a lipophilic model drug into a long-chain triglyceride (olive oil) and an in vitro digestion test was combined with electron paramagnetic resonance (EPR) spectroscopy (X-Band). Additionally the progression of digestion was determined by means of high performance thin layer chromatography (HPTLC).

RESULTS

The spectral shape of the EPR spectrum changed significantly during the digestion process. EPR spectra at all times could be simulated with three species indicating a redistribution of the lipophilic model drug between olive oil, phosphate buffer and mixed micelles formed by bile salts and phospholipids.

CONCLUSION

This in vitro real-time analysis could be a very helpful tool to monitor the digestibility of novel lipid-based drug nanocarriers which is an important step to optimize and to predict drug delivery processes. In future the EPR monitoring of fat digestion will be transferred to in vivo experiments.

摘要

相似文献

1
Monitoring of in vitro fat digestion by electron paramagnetic resonance spectroscopy.
Pharm Res. 2006 Sep;23(9):2024-9. doi: 10.1007/s11095-006-9069-3. Epub 2006 Aug 10.
2
ESR studies on the influence of physiological dissolution and digestion media on the lipid phase characteristics of SEDDS and SEDDS pellets.
Int J Pharm. 2009 Feb 9;367(1-2):29-36. doi: 10.1016/j.ijpharm.2008.09.014. Epub 2008 Sep 18.
3
Investigation of TEMPO partitioning in different skin models as measured by EPR spectroscopy - Insight into the stratum corneum.通过电子顺磁共振波谱法研究 TEMPO 在不同皮肤模型中的分配情况 - 深入了解角质层。
J Magn Reson. 2020 Jan;310:106637. doi: 10.1016/j.jmr.2019.106637. Epub 2019 Nov 11.
4
Spin Probe Multi-Frequency EPR Study of Unprocessed Cotton Fibers.未加工棉纤维的自旋探针多频电子顺磁共振研究
Cell Biochem Biophys. 2017 Jun;75(2):211-226. doi: 10.1007/s12013-017-0787-4. Epub 2017 Mar 7.
5
Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN).常用的酸碱滴定法真的能量化脂质药物递送系统的酶消化率吗?以固体脂质纳米粒(SLN)为例的研究。
Eur J Pharm Biopharm. 2016 Dec;109:194-205. doi: 10.1016/j.ejpb.2016.10.007. Epub 2016 Oct 24.
6
Morphological observations on a lipid-based drug delivery system during in vitro digestion.基于脂质的药物递送系统在体外消化过程中的形态学观察
Eur J Pharm Sci. 2007 Jun;31(2):85-94. doi: 10.1016/j.ejps.2007.02.009. Epub 2007 Feb 23.
7
Monitoring galactolipid digestion and simultaneous changes in lipid-bile salt micellar organization by real-time NMR spectroscopy.实时 NMR 光谱法监测半乳糖脂的消化和脂质-胆汁盐胶束组织的同时变化。
Chem Phys Lipids. 2024 Jan;258:105361. doi: 10.1016/j.chemphyslip.2023.105361. Epub 2023 Nov 21.
8
Column and high-performance size exclusion chromatography applications to the in vivo digestibility study of a thermoxidized and polymerized olive oil.柱色谱和高效尺寸排阻色谱在热氧化聚合橄榄油体内消化率研究中的应用
Lipids. 1999 Nov;34(11):1187-92. doi: 10.1007/s11745-999-0470-9.
9
The effect of lipophilicity of spin-labeled compounds on their distribution in solid lipid nanoparticle dispersions studied by electron paramagnetic resonance.
J Pharm Sci. 2003 Jan;92(1):58-66. doi: 10.1002/jps.10277.
10
The use of election paramagnetic resonance spectroscopy in early preformulation experiments: the impact of different experimental formulations on the release of a lipophilic spin probe into gastric juice.电子顺磁共振波谱在早期制剂前实验中的应用:不同实验制剂对亲脂性自旋探针释放到胃液中的影响。
Eur J Pharm Biopharm. 2001 Mar;51(2):159-62. doi: 10.1016/s0939-6411(00)00151-x.

引用本文的文献

1
Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.脂质相关的口服给药:口服吸收增强的机制与分析
J Control Release. 2016 Oct 28;240:544-560. doi: 10.1016/j.jconrel.2016.07.050. Epub 2016 Aug 9.
2
Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations.基于脂质的制剂的药代动力学方面及体外-体内相关性潜力。
Acta Pharm Sin B. 2014 Oct;4(5):333-49. doi: 10.1016/j.apsb.2014.09.001. Epub 2014 Oct 8.
3
Self-assembled structures formed during lipid digestion: characterization and implications for oral lipid-based drug delivery systems.

本文引用的文献

1
Monitoring drug delivery processes by EPR and related techniques--principles and applications.用电子顺磁共振及相关技术监测药物递送过程——原理与应用
Adv Drug Deliv Rev. 2005 Jun 15;57(8):1171-90. doi: 10.1016/j.addr.2005.01.023. Epub 2005 Apr 15.
2
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine.利用体外脂质消化数据解释难溶性药物基于甘油三酯的口服脂质制剂的体内性能:卤泛群研究
J Pharm Sci. 2004 May;93(5):1110-21. doi: 10.1002/jps.20039.
3
Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.
脂质消化过程中形成的自组装结构:特性及对口服脂质给药系统的意义。
Drug Deliv Transl Res. 2014 Jun;4(3):275-94. doi: 10.1007/s13346-013-0168-5.
4
Effect of ingested lipids on drug dissolution and release with concurrent digestion: a modeling approach.摄入的脂类对伴随消化的药物溶解和释放的影响:一种建模方法。
Pharm Res. 2013 Dec;30(12):3131-44. doi: 10.1007/s11095-013-1238-6.
5
Characterising lipid lipolysis and its implication in lipid-based formulation development.表征脂质的脂解作用及其在基于脂质的制剂开发中的意义。
AAPS J. 2012 Dec;14(4):860-71. doi: 10.1208/s12248-012-9398-6. Epub 2012 Sep 7.
难溶性药物在甘油三酯脂质中混悬液制剂的体外消化过程中的药物增溶行为。
Pharm Res. 2004 Feb;21(2):254-60. doi: 10.1023/b:pham.0000016283.87709.a9.
4
Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations.简单甘油三酯脂质溶液制剂体外消化过程中的药物增溶行为。
Pharm Res. 2004 Feb;21(2):245-53. doi: 10.1023/b:pham.0000016282.77887.1f.
5
On the concentration of bile acids in the human intestine during absorption. Bile acids and sterioids 74.关于人体肠道吸收过程中胆汁酸的浓度。胆汁酸与类固醇74。
Acta Physiol Scand. 1959 Aug 31;46:339-45. doi: 10.1111/j.1748-1716.1959.tb01763.x.
6
Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study.固体脂质纳米粒及载油固体脂质纳米粒的物理化学研究:核磁共振与电子自旋共振研究
Pharm Res. 2003 Aug;20(8):1274-83. doi: 10.1023/a:1025065418309.
7
Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products.长链和中链甘油酯的体外消化特性及其脂解产物的相行为评估。
J Pharm Pharmacol. 2002 Jan;54(1):29-41. doi: 10.1211/0022357021771896.
8
A dynamic in vitro lipolysis model. II: Evaluation of the model.一种动态体外脂肪分解模型。II:模型评估。
Eur J Pharm Sci. 2001 Oct;14(3):237-44. doi: 10.1016/s0928-0987(01)00182-8.
9
A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium.
Eur J Pharm Sci. 2001 Sep;14(2):115-22. doi: 10.1016/s0928-0987(01)00169-5.
10
Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis.采用高效薄层色谱法结合原位光密度分析对中链和长链甘油三酯及其体外消化产物进行表征和定量分析。
J Pharm Biomed Anal. 2001 Jun;25(3-4):651-61. doi: 10.1016/s0731-7085(00)00528-8.